IART
IART
NASDAQ · Health Care

Integra Lifesciences Holding

$14.38
+0.03 (+0.21%)
Financial Highlights (FY 2026)
Revenue
1.66B
Net Income
-522,981,856
Gross Margin
56.6%
Profit Margin
-31.6%
Rev Growth
+1.6%
D/E Ratio
1.78
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 56.6% 56.6% 67.3% 67.3%
Operating Margin -30.2% -27.2% 16.1% 18.5%
Profit Margin -31.6% -30.0% 14.6% 15.3%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 1.66B 1.63B 284.27M 289.60M
Gross Profit 937.55M 922.51M 191.26M 194.85M
Operating Income -500,898,274 -443,578,123 45.76M 53.46M
Net Income -522,981,856 -463,134,576 41.42M 44.34M
Gross Margin 56.6% 56.6% 67.3% 67.3%
Operating Margin -30.2% -27.2% 16.1% 18.5%
Profit Margin -31.6% -30.0% 14.6% 15.3%
Rev Growth +1.6% +1.6% +23.9% +16.2%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 357.34M 357.34M 104.07M 110.88M
Total Equity 200.89M 200.89M 274.89M 305.05M
D/E Ratio 1.78 1.78 0.38 0.36
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -485,730,822 -454,043,373 83.90M 77.61M
Free Cash Flow — — 47.45M 57.75M